Surgical Site Infection After Sacral Neuromodulation: Impact of Postoperative Antibiotics.

IF 0.8 Q4 OBSTETRICS & GYNECOLOGY Urogynecology (Hagerstown, Md.) Pub Date : 2025-01-17 DOI:10.1097/SPV.0000000000001627
Luke J King, Sarah L Ashmore, Hannah L Chapman, Collin M McKenzie, Bayley E Clarke, Sarah K Rozycki, Rodger W Rothenberger, Jared M Floch, Nageena R Khalid, Brittany L Roberts, Mildred N Bonglack, Charles R Rardin
{"title":"Surgical Site Infection After Sacral Neuromodulation: Impact of Postoperative Antibiotics.","authors":"Luke J King, Sarah L Ashmore, Hannah L Chapman, Collin M McKenzie, Bayley E Clarke, Sarah K Rozycki, Rodger W Rothenberger, Jared M Floch, Nageena R Khalid, Brittany L Roberts, Mildred N Bonglack, Charles R Rardin","doi":"10.1097/SPV.0000000000001627","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>There are limited data to guide practices to reduce surgical site infections following sacral neuromodulation; however, many surgeons prescribe prophylactic postoperative antibiotics after device implantation.</p><p><strong>Objective: </strong>The aim of the study was to compare the proportion of patients with sacral neuromodulation device-associated surgical site infections after use of prophylactic postoperative antibiotics versus none.</p><p><strong>Study design: </strong>This was a multicenter retrospective cohort study of patients undergoing sacral neuromodulation device implantation at 11 institutions from January 2014 to December 2023, comparing outcomes in patients who did versus did not receive prophylactic postoperative antibiotic treatment. The primary outcome was surgical site infection within 90 days. The proportions of surgical site infections were compared, and regression analyses were performed to identify variables associated with surgical site infection.</p><p><strong>Results: </strong>A total of 1,798 patients met inclusion criteria. Within this population, 67 surgical site infections (3.7%) were identified. Patients who received postoperative antibiotics (898/1798, 49.9%) were older (63.2 years vs 61.0 years, P < 0.001), and a greater proportion had staged procedures (57.9% vs 49.8%, P < 0.001). The proportion of surgical site infections and device explantations were not different between groups (3.6% vs 3.9%, P = 0.8) and (2.0% vs 2.8%, P = 0.2), respectively. After adjusting for age in a multivariate analysis, prophylactic postoperative antibiotic use was not associated with surgical site infections (0.98, 95% CI: 0.61-1.61, P = 0.94).</p><p><strong>Conclusions: </strong>Rates of surgical site infection following device implantation are low. Our findings suggest that the use of prophylactic postoperative antibiotics has minimal effect on reducing infection after device implantation. Further research is needed to explore underlying factors influencing this relationship.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urogynecology (Hagerstown, Md.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/SPV.0000000000001627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: There are limited data to guide practices to reduce surgical site infections following sacral neuromodulation; however, many surgeons prescribe prophylactic postoperative antibiotics after device implantation.

Objective: The aim of the study was to compare the proportion of patients with sacral neuromodulation device-associated surgical site infections after use of prophylactic postoperative antibiotics versus none.

Study design: This was a multicenter retrospective cohort study of patients undergoing sacral neuromodulation device implantation at 11 institutions from January 2014 to December 2023, comparing outcomes in patients who did versus did not receive prophylactic postoperative antibiotic treatment. The primary outcome was surgical site infection within 90 days. The proportions of surgical site infections were compared, and regression analyses were performed to identify variables associated with surgical site infection.

Results: A total of 1,798 patients met inclusion criteria. Within this population, 67 surgical site infections (3.7%) were identified. Patients who received postoperative antibiotics (898/1798, 49.9%) were older (63.2 years vs 61.0 years, P < 0.001), and a greater proportion had staged procedures (57.9% vs 49.8%, P < 0.001). The proportion of surgical site infections and device explantations were not different between groups (3.6% vs 3.9%, P = 0.8) and (2.0% vs 2.8%, P = 0.2), respectively. After adjusting for age in a multivariate analysis, prophylactic postoperative antibiotic use was not associated with surgical site infections (0.98, 95% CI: 0.61-1.61, P = 0.94).

Conclusions: Rates of surgical site infection following device implantation are low. Our findings suggest that the use of prophylactic postoperative antibiotics has minimal effect on reducing infection after device implantation. Further research is needed to explore underlying factors influencing this relationship.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
骶骨神经调节术后手术部位感染:术后抗生素的影响。
重要性:指导实践减少骶神经调节后手术部位感染的数据有限;然而,许多外科医生在器械植入后开具预防性术后抗生素。目的:本研究的目的是比较术后预防性使用抗生素与未使用抗生素的患者发生骶神经调节装置相关手术部位感染的比例。研究设计:这是一项多中心回顾性队列研究,研究对象是2014年1月至2023年12月在11家机构接受骶骨神经调节装置植入的患者,比较接受和未接受预防性术后抗生素治疗的患者的结果。主要结果为90天内手术部位感染。比较手术部位感染的比例,并进行回归分析以确定与手术部位感染相关的变量。结果:共有1798例患者符合纳入标准。在这一人群中,发现67例手术部位感染(3.7%)。术后接受抗生素治疗的患者(898/1798,49.9%)年龄较大(63.2岁vs 61.0岁,P < 0.001),分阶段手术的比例较大(57.9% vs 49.8%, P < 0.001)。手术部位感染和器械解释的比例在两组间无差异(分别为3.6% vs 3.9%, P = 0.8)和(2.0% vs 2.8%, P = 0.2)。在多因素分析中调整年龄后,预防性术后抗生素使用与手术部位感染无关(0.98,95% CI: 0.61-1.61, P = 0.94)。结论:器械植入后手术部位感染发生率低。我们的研究结果表明,术后预防性抗生素的使用对减少器械植入后感染的影响微乎其微。需要进一步的研究来探索影响这种关系的潜在因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
期刊最新文献
Adverse Events Associated With Female External Urinary Collection Devices. Tamsulosin to Prevent Urinary Retention After Vaginal Urogynecologic Surgery. The Effect of Concomitant Hysterectomy Route on Robotic Sacrocolpopexy Outcomes. Urogynecology Research Is Underrepresented in Top Obstetrics and Gynecology Journals. Treatment Crossover Following Advanced Therapy for Overactive Bladder Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1